linjc16/ctgov huggingface dataset:
Food Survey, Curbside, Remote APPs SC

Study Overview
=================
Brief Summary
-----------------
The proposed research will create accurate and standardized household FW measurement methodologies that foster serial and longitudinal assessments as well as confident and convenient one-time measurement by stakeholders. The investigators will have participants simutaneously deploy (1) retrospective surveys (2) curbside audits.

Official Title
-----------------
An Innovative, Accessible, and Flexible Approach for Household Food Waste Measurement

Conditions
-----------------
Waste Management, Recycling, Climate, Nutrition Sciences

Intervention / Treatment
-----------------
* Other: Survey Curbside


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or Female, age 18 years and older Willing and able to store household food waste for curbside pickup by a third-party waste pickup company Internet or Wi-Fi availability to complete online surveys Exclusion Criteria: Not willing to adhere to study procedures and study visit timelines Any condition or circumstance that in the judgement of the PI could interfere with study participation

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| SC<br>Food Waste Tracking Survey and Curbside over 2 consecutive weeks | Other: Survey Curbside<br>* Observational. Waste will be collected on specific days for 2 consecutive weeks and surveys will be completed to coincide with the waste collections.<br>* Other names: SC;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Total Household Food Waste | Weight | 1 week | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Household Food Waste Energy | Energy (kcal) | 1 week |
Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c

Study Overview
=================
Brief Summary
-----------------
Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.

Detailed Description
-----------------
The foundation for cardiovascular health (CVH) is laid in early life by intergenerational interactions, passed from parent to child, that have long-lasting biological and behavioral consequences. Lifestyle interventions can promote CVH among mothers and their children over time. Academic partnerships with home visiting organizations that reach families experiencing health disparities advance intergenerational CVH equity. For this pilot study we are testing the feasibility of doing remote data collection with a point of care device that measures HbA1c to use in the main study.

Official Title
-----------------
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting

Conditions
-----------------
Pregnant, Postpartum

Intervention / Treatment
-----------------
* Diagnostic Test: Point of care device to measure HbA1c


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: English speaking Screened or participating in NCT04253977 Able to give informed consent for participation Exclusion Criteria: -

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: Point of care device to measure HbA1c|After consent the participant will meet with the research team virtually to obtain HbA1c. The HbA1c self check equipment will be sent to the participant. During the video call the research team will talk the participant through obtaining their HbA1c with the point of care device.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Feasibility to obtain HbA1c through remote data collection | Feasibility will be measured by how many participants are able to obtain HbA1c measure through remote data collection and participant's satisfaction with this means of data collection. | Baseline |
99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis

Study Overview
=================
Brief Summary
-----------------
This prospective study will investigate the potential usefulness of 99mTc labeled FAPI SPECT/CT in the diagnosis, treatment response assessment, and follow-up of pulmonary fibrosis.

Detailed Description
-----------------
Idiopathic pulmonary fibrosis refers to a specific form of chronic fibrous interstitial pneumonia that occurs spontaneously, limited to the lung, and shows features of usual interstitial pneumonia on high resolution computed tomography and histological examination. Radionuclide labeled FAPI has been developed as a new tracer for tumor and inflammatory lesions imaging. Recent studies have shown that FAPI PET/CT imaging is a promising new imaging method for pulmonary fibrosis. HFAPI is obtained by conjugating 99mTc-chelator moiety (6-hydrazinonicotinamide, HYNIC) with FAP targeting moiety. The aim of this study is to investigate the location and extent of 99mTc labeled FAPI tracer (99mTc-HFAPI) in normal and fibrotic lung tissue of patients with pulmonary fibrosis, and to explore the clinical significance of 99mTc-HFAPI SPECT/CT in the diagnosis, treatment response evaluation and follow-up of pulmonary fibrosis.

Official Title
-----------------
99mTc-Labeled FAPI SPECT Imaging in Pulmonary Fibrosis

Conditions
-----------------
Pulmonary Fibrosis

Intervention / Treatment
-----------------
* Drug: 99mTc-HFAPI


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: suspected or confirmed pulmonary fibrosis patients; signed written consent. Exclusion Criteria: pregnancy; breastfeeding; known allergy against FAPI any medical conditions that are considered by the investigator to be likely to seriously interfere with study compliance

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Patients diagnosed with pulmonary fibrosis<br>Patients of Pulmonary Fibrosis SPECT/CT imaging: The patients were subcutaneously injected with 99mTc-HFAPI and underwent SPECT/CT imaging. | Drug: 99mTc-HFAPI<br>* Each patient receive a intravenous injection of 99mTc-HFAPI, and undergo SPECT/CT scan within specified time.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Diagnostic accuracy | Qualitative and semi-quantitative analysis (T/N ratio of lesions and adjacent normal tissue, and early and late imaging) of 99mTc-HFAPI SPECT/CT for pulmonary fibrosis | through study completion, an average of 1.5 years |
Accuracy of Different Technologies for Dental Cast Digitization; CBCT Versus Desktop Optical 3D Scanner

Study Overview
=================
Brief Summary
-----------------
The objective of this study is to evaluate and compare the accuracy of digital dental models generated from plaster casts by two different scanning techniques including Cone Beam Computed Tomography (CBCT) and extraoral Scanner (EOS) . The comparison between the two techniques is assessed by orthodontic arch space analysis using linear measurements for arch length and width .

Official Title
-----------------
Accuracy of Different Technologies for Dental Cast Digitization; CBCT Versus Desktop Optical 3D Scanner: An Observational Study

Conditions
-----------------
Evaluate and Compare the Accuracy of Digital Dental Models Generated From Plaster Casts by Two Different Scanning Techniques

Intervention / Treatment
-----------------
* Device: linear measurement


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with maxillary or mandibular complete permanent dentition Partially edentulous patients provided the dentition are complete from the first molar to the first molar. Exclusion Criteria: Patients with fractured teeth, attrition and/or erosion affecting the anatomical points Patients having non-anatomic restorations that may alter cusp anatomy affecting the accuracy of measurements consequently.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Dental Cast Digitization techniques:(CBCT 3D model scanning module )<br>Scanning the plaster model using CBCT 3d model scanning module to generate a digital model | Device: linear measurement<br>* Linear measurements from digital caliper ,CBCT and EOS generated digital dental models<br>|
| Dental Cast Digitization techniques :Desktop Optical 3D Scanner<br>Scanning the plaster model using Desktop Optical 3D Scanner to generate a digital model | Device: linear measurement<br>* Linear measurements from digital caliper ,CBCT and EOS generated digital dental models<br>|
| plaster cast<br>linear measurments on the plaster cast as the gold standard (using the digital caliper ) | Device: linear measurement<br>* Linear measurements from digital caliper ,CBCT and EOS generated digital dental models<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Deviation of CBCT and extraoral scanner's measurements from gold standard in arch space analysis. | Evaluate and compare the accuracy of digital dental models generated from plaster casts by two different scanning techniques including Cone Beam Computed Tomography (CBCT) and extraoral Scanner (EOS). | one year |
The Effect of Lipmatte K

Study Overview
=================
Brief Summary
-----------------
This study is conducted to evaluate the safety and the effectiveness of Lipmatte K on lip hydration and brightening. The study duration is 4 weeks and the lip assessment will be carried out at baseline, week 2 and week 4.The main questions this study aims to answer are: The hydration effect of the product on lip. The brightening effect of the product on lip. To observe any adverse effect occurrence with the usage of the product.

Official Title
-----------------
The Effect of Lipmatte K on Lip Hydration and Brightening

Conditions
-----------------
Aesthetic, Cosmetic, Healthy

Intervention / Treatment
-----------------
* Other: Lipmatte K


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Malaysia citizen Female (age 30-55 years old) Lip with mild-to-moderate dryness Exclusion Criteria: Subjects who have history of performing lips-related treatments such as lip augmentation (filler, botox, laser) Heavy lips desquamation or chapped lip conditions

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 55 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Lipmatte K<br>Participants will used Lipmatte K everyday for 4 weeks | Other: Lipmatte K<br>* Lipmatte K contain ingredients that may hydrate and brighten the lip<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in lip roughness from baseline and at week 2 and 4 after using Lipmatte K | Degree of lip roughness for each participant's will be determined by dermatologist based on score 0 to 2 (0= no desquamations, 1 = slight desquamations and 2 = heavy desquamations) | Baseline, Week 2, Week 4 | 
| Change in lip wrinkles from baseline and at week 2 and 4 after using Lipmatte K | Degree of lip wrinkle for each participant's will be determined by dermatologist based on score 0- 2 (0 = no/almost no vertical wrinkles, 1 = no deep vertical wrinkles and 2 = many deep vertical wrinkles) | Baseline, Week 2, Week 4 | 
| Visual assessment of the lip from baseline and at week 2 and 4 after using Lipmatte K | Image of the lip will be captured using digital camera (Nikon D5100) to observed the brightening effect of the lipmatte | Baseline, Week 2, Week 4 | 
| Adverse effect after using Lipmatte K | Based on adverse effect occurrence on participants that occur during study period (4 weeks) | Week 4 |
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Study Overview
=================
Brief Summary
-----------------
To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.

Official Title
-----------------
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue (PRESERVE GBM)

Conditions
-----------------
Glioblastoma, Glioblastoma Multiforme, Gliosarcoma

Intervention / Treatment
-----------------
* Procedure: Specimen Collection


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Have the appearance of high-grade glioma on magnetic resonance (MR) imaging if allowed to consent and will undergo the procedure if the frozen is consistent with glioblastoma or gliosarcoma OR Patients with a history of histologically confirmed diagnosis of World Health Organization Grade glioblastoma or gliosarcoma that are undergoing repeat resection of a recurrent tumor as identified on preoperative MR imaging Aged ≥ 18 years old Contrast-enhancing tumor volume of at least 10 cc on the preoperative, volumetric MRI within 1 month prior to surgery Provision of signed and dated informed consent form by participant or legally authorized representative (LAR), if applicable Exclusion Criteria: 1. Has a history or current evidence of any medical condition, therapy, or laboratory abnormality that might confound the results of the study or is not in the best interest of the participant, in the opinion of the treating investigator.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Glioblastoma<br>Surgical tumor resection as standard of care and specimen collection | Procedure: Specimen Collection<br>* Collect and preserve glioblastoma tissue for exploratory analyses to generate hypotheses for future studies.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of glioblastoma (GBM) samples for analysis | Total number of GBM samples collected and preserved for analysis | 2 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
specimen banking
Prevalence and Incidence of Multiple Revisions Following Knee Arthroplasty in Denmark 1998-2021: A Nationwide Population-based Study

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to investigate the incidence and prevalence rates of multiply revised knee arthroplasty patients in Denmark from 1998-2021.

Official Title
-----------------
Prevalence and Incidence of Multiple Revisions Following Knee Arthroplasty in Denmark 1998-2021: A Nationwide Population-based Study

Conditions
-----------------
Knee Replacement, Knee Replacement Revision

Intervention / Treatment
-----------------
* Procedure: Revision


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Danish Resident between 18-99 years of age must have had primary knee arthroplasty procedure performed in Denmark between 1998-2021 Exclusion Criteria: Missing key variables (patient ID, date of surgery, procedure-code, laterality of procedure) Duplicates Non-relevant procedures

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Primary cohort<br>All patients with a primary knee arthroplasty performed in Denmark between Jan 1st 1998 and 31st December 2021. | |
| Revision cohort<br>All patients with a revision knee arthroplasty performed in Denmark between Jan 1st 1998 and 31st December 2021 | Procedure: Revision<br>* Any type of knee revision, excluding knee arthrodesis and femur amputation<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of major n-grade revisions | standardized prevalence of major n-grade revisions | 23 years | 
| Incidence of major n-grade revisions | standardized incidence of major n-grade revisions | 23 years | 
| Prevalence of all n-grade revisions | standardized prevalence of all n-grade revisions | 23 years | 
| Incidence of all n-grade revisions | standardized incidence of all n-grade revisions | 23 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of major and all n-grade revisions stratified by sex and age | Calculation of incidence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99) | 23 years | 
| Prevalence of major and all n-grade revisions stratified by sex and age | Calculation of prevalence for major and for all n-grade revisions stratified by sex and by age (groups, sex: male/female, age: 18-49/50-69/70-99) | 23 years | 
| Prevalence of major and all n-grade revisions for patients with their total sum of revisions | Calculation of standardized prevalence for patients receiving major or all type of n-grade revision, where the ordering of revisions are not knee specific but patient-specific | 23 Years |
Radiomic Modeling in Differentiating Uncomplicated From Complicated Acute Appendicitis

Study Overview
=================
Brief Summary
-----------------
Non-operative management (NOM) with antibiotics may be a safe alternative to surgery for uncomplicated appendicitis, but preoperative differentiation between uncomplicated and complicated appendicitis is challenging. The study aimed to develop a clinical-radiomics nomogram to distinguish uncomplicated from complicated appendicitis.

Official Title
-----------------
Development and Validation of an Individualized Nomogram to Differentiate Uncomplicated From Complicated Acute Appendicitis in Adults: a Multicenter Study

Conditions
-----------------
Acute Appendicitis

Intervention / Treatment
-----------------
* Diagnostic Test: without


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Pathologically diagnosed as acute appendicitis after appendectomy between January 2021 and December 2022. Exclusion Criteria: age less than 18 years (no upper age limit); without CT examination within a week before surgery; difficult to outline the contours of the appendix due to inflammatory exudate; lack of clinical information.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Training cohort<br>Model construction based on training cohort | Diagnostic Test: without<br>* without<br>|
| Validation cohort 1<br>Model validation in an independent validation cohort 1 | Diagnostic Test: without<br>* without<br>|
| Validation cohort 2<br>Model validation in an independent validation cohort 2 | Diagnostic Test: without<br>* without<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Accuracy of clinical-radiomic model for differentiating complicated from uncomplicated appendicitis | ROC curve will be plotted and the area under ROC curve will be compared | January 2021 to December 2022 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
acute appendicitis, diagnosis, nomogram